[EN] SMALL MOLECULES FOR IMMUNOGENIC TREATMENT OF CANCER<br/>[FR] PETITES MOLÉCULES POUR LE TRAITEMENT IMMUNOGÈNE DU CANCER
申请人:CAPTEN THERAPEUTICS INC
公开号:WO2017180769A1
公开(公告)日:2017-10-19
The present invention relates to new compounds for immunogenic treatment of cancer. The compounds can be administered as a single agent or in combination with an anticancer drug including modulators of other immune pathways, especially immune checkpoint inhibitors that target CTLA-4, PD-1, and PD-L1 proteins. The compounds can produce neoantigens through irreversible protein binding in cancer cells and generate immune response.